Explore more topics
SEC reporting owner

Vander Vort John SEC insider disclosures

Explore Vander Vort John's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-13T06:40:31.983Z

Reporting owner CIK
0001379218
Issuers
8
Coverage
verified
Jump to a section

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Scroll sideways to compare all columns. Select a heading to sort.

MEMORY PHARMACEUTICALS CORP0001062216MEMYNoNo
Radius Health, Inc.0001428522RDUSYesYes
PEPLIN INC0001408808PLINNoNo
Pacira Pharmaceuticals, Inc.0001396814PCRXNoNo
Verastem, Inc.0001526119VSTMNoNo
Epizyme, Inc.0001571498EPZMNoNo
ARATANA THERAPEUTICS, INC.0001509190PETXNoYes
Conatus Pharmaceuticals Inc0001383701CNATNoNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.